New drug challenge for tough lung cancer
NCT ID NCT02767804
Summary
This study aims to see if a new drug called ensartinib works better and is safer than the standard drug crizotinib for people with a specific type of advanced lung cancer (ALK-positive NSCLC). It will involve about 290 adults who have had up to one prior chemotherapy treatment. The main goal is to see which drug better controls the cancer and delays its progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anhui Provincial Hospital
Hefei, Anhui, 230001, China
-
Asan Medical Center
Seoul, 05505, South Korea
-
Azienda Socio Sanitaria Territoriale (ASST) della Valtellina e dell'Alto Laria
Sondrio, 20121, Italy
-
BIH of Omsk Region "Clinical Oncology Dispensary"
Omsk, Russia
-
Beijing Chao Yang Hospital
Beijing, Beijing Municipality, 100020, China
-
Beijing Chest Hospital,Capital Medical University
Beijing, Beijing Municipality, 101149, China
-
Blackpool Victoria Hospital
Blackwood, FY3 8NR, United Kingdom
-
Border Medical Oncology Research Unit
Albury, New South Wales, 2640, Australia
-
CHRU Lille
Lille, 59000, France
-
CHU de Rennes Hôpital Pontchaillou
Rennes, 35033, France
-
Catholic University of Louvain (UCL) - Site Mont Godinne
Yvoir, 5530, Belgium
-
Centro Operativo Studi Clinici S.C.Oncologia Medica
Perugia, 06132, Italy
-
Charite Campus Virchow-Klinikum
Berlin, 13353, Germany
-
Chris O Brien Lifehouse
Camperdown, Australia
-
Chris O'Brien Lifehouse
Camperdown, New South Wales, Australia
-
Federal State Budgetary Scientific Institution Russian Oncological Scientific Center named after N.N. Blokhin
Moscow, 115478, Russia
-
Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050011, China
-
Fujian Provincial Cancer Hospital
Fuzhou, Fujian, 350014, China
-
Fundacao do ABC Faculdade de Medicina do ABC
São Paulo, Brazil
-
Guangdong General Hospital
Guangzhou, Guangdong, 510080, China
-
Hadassah Medical Center
Jerusalem, 9112001, Israel
-
Hopital Arnaud de Villeneuve
Montpellier, 34298, France
-
Hopital Saint-Louis
Vellefaux, France
-
Hospital Haroldo Juaçaba - Instituto do Cancêr do Ceará
Fortaleza, 60351-010, Brazil
-
Hospital Son Ltatzer
Palma de Mallorca, 07198, Spain
-
Hospital Vall d'Hebrón
Barcelona, 08035, Spain
-
Hospital de Câncer de Barretos - Fundação Pio XII
São Paulo, São Paulo, 14784-400, Brazil
-
Hospital de la Santa Creu i Sant Pau
Barcelona, 08025, Spain
-
Hospital del Mar
Barcelona, 08003, Spain
-
Hubei Cancer Hospital
Wuhan, Hubei, 430079, China
-
Hunan Cancer Hospital
Changsha, Hu'nan, 410006, China
-
IEO Istituto Europeo di Oncologia
Milan, 20141, Italy
-
Infirmière recherche Clinique, IUCPQ
Québec, Quebec, G1V 4G5, Canada
-
Instituto do Câncer do Estado de São Paulo
São Paulo, São Paulo, 01246-000, Brazil
-
Jilin Cancer Hospital
Changchun, Jilin, 130012, China
-
Kings Mill Hospital
Nottingham, NG17 4JL, United Kingdom
-
Krajská zdravotní, a.s., Masarykova nemocnice
Ústí nad Labem, 40113, Czechia
-
LLC "Vitamed"
Moscow, 121309, Russia
-
Lungen Clinic Grosshansdorf
Großhansdorf, 22927, Germany
-
Maastricht University Medical Centre (MUMC)
Maastricht, 6229HX, Netherlands
-
Medical University of Gdansk
Gdansk, Poland
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Moscow City Oncology Hospital #63
Moscow, 143423, Russia
-
Nanjing General Hospital
Nanjing, Jiangsu, 210002, China
-
Pavlov First Medical University
Saint Petersburg, 197022, Russia
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100032, China
-
Peking University Cancer Hospital
Beijing, Beijing Municipality, 100142, China
-
Peking University Cancer Hospital
Beijing, 100142, China
-
Petrov Research Institute of Oncology
Saint Petersburg, Russia
-
Prince of Wales Hospital
Hong Kong, Hong Kong
-
Prince of Wales Hospital
Shatin, Hong Kong
-
Providence Portland Medical Center
Portland, Oregon, 97213, United States
-
Queen Elizabeth Hospital
Hong Kong, Hong Kong
-
Rabin Medical Center Institute of Oncology, Davidoff Center
Petah Tikva, 49100, Israel
-
Sanatorio Parque S.A.
Rosario, Argentina
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, 200030, China
-
Southmead Hospital
Bristol, BS10 5NB, United Kingdom
-
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, 266071, China
-
The Clatterbridge Cancer Centre NHS Foundation Trust
Metropolitan Borough of Wirral, CH63 4JY, United Kingdom
-
The First Bethune Hospital of Jilin University
Changchun, Jilin, 130000, China
-
The First Hospital of China Medical University
Shenyang, Liaoning, 110001, China
-
The University of Hong Kong/Queen Mary Hospital
Hong Kong, Hong Kong
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
Wuhan, Hubei, 430030, China
-
Trakya University Balkan Oncology Hospital
Edirne, 22030, Turkey (Türkiye)
-
Union Hospital of Tongji Medical College of Huazhong Science and Techology University
Wuhan, Hubei, 420104, China
-
University Cancer & Blood Center
Athens, Georgia, 30607, United States
-
VU Medical Center
Amsterdam, 1007 MB, Netherlands
-
Vítkovická Nemocnice , a.s.
Ostrava-Vitkovice, 70384, Czechia
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, 310022, China
-
Zhejiang Cancer Hospital
Hangzhou, China
Conditions
Explore the condition pages connected to this study.